Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas.

Attia, Steven; Villalobos, Victor; Hindi, Nadia; Wagner, Andrew J; Chmielowski, Bartosz; Oakley, Gerard J; Peterson, Patrick M; Ceccarelli, Matteo; Jones, Robin L; Dickson, Mark A.

Attia S; Mayo Clinic, Jacksonville, FL 32224, USA.
Villalobos V; School of Medicine, University of Colorado Denver, Aurora, CO 80045, USA.
Hindi N; Hospital Universitario Virgen del Rocío, 41013 Sevilla, Spain.
Wagner AJ; Fundación Jiménez Díaz University Hospital, 28040 Madrid, Spain.
Chmielowski B; Hospital General de Villalba, 28400 Madrid, Spain.
Oakley GJ; Center for Sarcoma and Bone Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
Peterson PM; Harvard Medical School, Boston, MA 02115, USA.
Ceccarelli M; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA 90024, USA.
Jones RL; Eli Lilly and Company, Indianapolis, IN 46255, USA.
Dickson MA; Eli Lilly and Company, Indianapolis, IN 46255, USA.